GSK to consolidate vaccines R&D ahead of Novartis unit takeover
GSK will close a vaccine R&D lab in Montana and establish a centralised development hub as it prepares to takeover Novartis jabs unit.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs